Company:

News and Publications

Knowledge and perspectives are most powerful when they are communicated to many. Through the depth of our work and wide industry exposure, Putnam Associates uncovers the strategic questions and commercialization challenges that confront drugs, diagnostics and biomedical products. Our news and publications address these issues and share the information that leads to better-informed decisions. Learn more about our growth, ideas and successes:

News:

Boston Business Journal interviewed Kevin Gorman and quoted him in the article "Bio Companies Come to Grips with Gift Ban," June 26-July 2, 2009, by Julie Donnelly

The Boston Globe interviewed Kevin Gorman and Domenick Bertelli and quoted them in a front-page feature article entitled, "Virus Shuts Genzyme Plant, Holds Up Drugs for 8,000," by Erin Ailworth and Robert Weisman, June 17, 2009

Boston Business Journal published Domenick Bertelli's comments on the diabetes and obesity market in "Bay State Biotech Firms Targeting the Fat of the Land," by Julie M. Donnelly, June 5-11, 2009

Kevin J. Gorman, Managing Partner, is chair and panelist of "The Struggle to Maintain Global Market Access for Innovative Biologic Products: Strategic, Economic and Product Security Perspectives" at 2009 BIO (Biotechnology Industry Organization) International Convention

In celebration of its 20th anniversary, Putnam Associates has published The First Twenty Years Are the Hardest: Two Decades in Healthcare Strategy, a collection of perspectives from a cross section of experts in healthcare

Domenick Bertelli Promoted to Partner

Putnam Associates Reports on Leveraging Physician Segmentation to Develop Brand Strategy

Forbes.com published Kevin Gorman's comments on "Health Care Policy: Will Reform Become Reality," the panel discussion in which he spoke at the 2009 Annual Wharton Health Care Business Conference, "Catalyzing Change: Accelerating Health Care Advancement." Knowledge®Wharton is the author of this article entitled, "Health Reform is Nigh," (March 5, 2009)

BioProcess International (March 2009) quoted Kevin Gorman in the chapter, "A World of Possibilities: Global/International Biotechnology Issues," on the struggle to maintain global market access for innovative biologic products including strategic, economic and product security perspectives, the topic of the panel discussion which Mr. Gorman will chair at the 2009 BIO International Convention, Atlanta, May 18-21, 2009

Knowledge@Wharton in the article, "'Major League, Middle Class Anxiety': Is the U.S. Closer to Universal Health Care?" (March 4, 2009) published Kevin Gorman's comments on "Health Care Policy: Will Reform Become Reality," the panel discussion in which he spoke at the 2009 Annual Wharton Health Care Business Conference, "Catalyzing Change: Accelerating Health Care Advancement."

Kevin J. Gorman to Speak at Wharton's 2009 Health Care Business Conference, February 20, 2009

Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Some Early Efforts Under Obama Could Impact Specialty Pharmacy," November 2008

Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Economic Downturn Hits Specialty Industry Hard; Stakeholder Responses Are Varied," November 2008

Interview with Kevin Gorman and Paul Bogorad in Drug Benefit News, "Removal of Ranbaxy Generic Rxsls Not Likely to Have Major Impact", October 3, 2008

Interview with Kevin Gorman in Drug Benefit News, "Weak Economy, Cash-Strapped Consumers May Take Toll on Pharmaceutical Benefits", October 3, 2008

Interview with Eric Auger and Ricky Joshi in Specialty Pharmacy News, "Psoriasis Can Have Significant Health Impact; Plan Understanding May Be Lacking," July 2008

Putnam Associates Celebrates Its 20th Anniversary

Interview with Richard Tinsley and Paul Bogorad in Specialty Pharmacy News, "Multiple Copays, Management Tools May Influence Influence HIV/AIDS Patients' Compliance," April 2008

Interview with John Baskey in Pharmaceutical Commerce, "Generic Manufacturers Plan Aggressive Challenges of Branded Products During 2008-2016: Paragraph IV challenges already target 57% of potential remaining product sales," January-February 2008 issue

Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Outlook 2008: HIV, Oncology are Among Areas That Will See Therapeutic Impact," January 2008

Interview with Eric Auger in Drug Benefit News, "First Genric Protonix Hits the Market; Plans, PBMs Expect Modest Savings at First," January 18, 2008

Putnam Associates Reports on Rapidly Changing Generic Industry

Putnam Associates Study Finds Insurers Want More Prescription Drug Use

For the Fifth Year in a Row, Putnam Associates named one of the top 50 Strategy Consulting Firms

Consulting Magazine Names Putnam Associates a Leader Among Nation's Firms

Inflection Point Articles:

Leveraging Physician Segmentation to Develop Brand Strategy: Getting More From Physician Segmentation

Not Your Father's Generics: How A Rapidly Changing Global Generic Industry is Challenging Lifecycle Planning

US Managed Markets: Opportunities and Risks in the Emerging Appropriate Use Paradigm

Alliance Management - Fix it Before it Breaks: Alliance Diagnostic and Repair

Nurse Practitioners and Physician Assistants: Often Untapped for Sales and Marketing Initiatives

For more information about our news and publications, email Kevin Gorman.